glp1
Zepbound (tirzepatide) tracker
Educational reference for Zepbound (tirzepatide). Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
120 h
Tmax
24 h
Category
glp1
Zepbound is Eli Lilly's brand of tirzepatide for chronic weight management.
Mechanism
Zepbound is a brand name for tirzepatide, a dual GIP and GLP-1 receptor agonist, at doses used for weight management. See the tirzepatide entry for the full mechanism.
Research summary
Zepbound is the tirzepatide product approved for chronic weight management (SURMOUNT program). See the tirzepatide entry for broader context.
Reported side effects
As a tirzepatide product, gastrointestinal effects are most commonly reported; prescribing information includes class warnings. See the tirzepatide entry. This is not a complete safety profile.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- Zepbound prescribing information · FDA prescribing information (2023)available via DailyMed; see tirzepatide entry
References
TrackPep은 기록용 앱입니다. 사용자가 입력한 내용만 기록하며, 투여량을 추천하거나 계산하지 않습니다.